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Obesity is a risk factor for poor iron status due to the chronic, low-grade 
inflammation of adipose tissue hypertrophy.  Among other positive acute phase proteins, 
the hepatic peptide hormone hepcidin is secreted during inflammation, inhibiting 
systemic iron efflux from enterocytes and downregulating systemic iron recycling by 
suppressing iron release from the mononuclear phagocyte system.  Conversely, 
production and secretion of the iron transport protein transferrin by the liver is reduced 
during inflammation.  In addition to increasing adiposity, certain foods are also known to 
promote inflammatory states and may contribute to these same effects in concert with, or 
independent of obesity.  In this study, we evaluated how inflammatory diets are related to 
inflammatory and iron status biomarkers among 98 young adults with normal weight, 
overweight and obesity.  Three-day dietary records and biomarker data for iron status and 
inflammation from two cross-sectional studies of similar design (Diet and Inflammation 
Study, n= 39 and the Selenium and Inflammation Study, n= 59) were used in this study.  
Dietary Inflammatory Index (DII) scores were calculated for each subject using nutrients 
and other dietary components from the dietary records, and subjects were further 
classified into two DII categories using cluster analysis.  Using ANOVA we compared 
iron status and inflammatory markers among subjects with normal weight, overweight 
and obesity.  We determined the association between DII scores or DII category and C-
reactive protein (CRP), hepcidin, serum iron and total iron binding capacity (TIBC).  
Statistical significance was set at P< 0.05.  Mean + SEM were reported for continuous 
 
 
variables except for skewed variables in which case geometric means (geometric mean 
+1SEM interval) were reported.  CRP concentration differed significantly by BMI 
category (p < 0.05 for all comparisons) and serum iron (SI) was lower in the obese 
category compared to normal weight (p=0.014). Results from the regression analysis 
showed that high DII scores were associated with increased CRP concentration and 
decreasing TIBC.  Similarly, subjects in the anti-inflammatory diet group showed higher 
TIBC compared to those in the inflammatory diet group.  In conclusion, our study 
showed that inflammatory diets may impair iron status by reducing the capacity of the 
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Beyond providing nutrients, certain foods offer other health benefits through 
unique properties such as their antioxidant and their anti-inflammatory properties. The 
effects of foods and their components on inflammation have been investigated in both 
observational and experimental studies (1–4).  In conjunction with epigenetic research, an 
understanding of how exposure to certain foods influences genetic expression and post 
translational modification of proteins is becoming well established (5–10).  The 
upregulation of inflammatory cytokines by food components is an important concept that 
continues to be widely studied as the mechanism by which phenotypic changes toward a 
chronic disease phenotype are born. 
Inflammatory cytokines are small proteins that play a primary role in local and 
systemic signaling that initiate the immune response to infection and injury.  Namely, an 
increase in interleukin 6 (IL-6), interleukin one beta (IL-1β), and tumor necrosis factor 
alpha (TNFα) are associated with an increase in the hepatic protein, C-Reactive protein 
(CRP) which binds to the surface of the affected cells to augment various immunological 
processes of the innate immune system (11,12). In addition to stimulating release of CRP, 
the hepatic peptide hormone, hepcidin is also released and its job is to keep a tight 





iron into the liver and macrophages, reduces iron absorption in the intestines and 
decreases iron efflux from enterocytes into the bloodstream.  
During the acute phase response, the immune system resolves pathophysiological 
threats and normal iron physiology can be restored.  However, individuals who are 
overweight or obese have been found to have chronically elevated levels of hepcidin and 
other markers of inflammation even in the absence of infection or injury resulting in poor 
iron status (13–19).  It is suspected that the increases in hepcidin and other inflammatory 
markers in the overweight and obese may be attributed to an accumulation of activated 
macrophages in adipose tissue that secrete adipocytokines including IL-6, and TNFα 
which activates transcription of the iron storage protein ferritin (20,21).  Atypical 
adaptations to iron metabolism during obesity related chronic inflammatory states are 
thus being observed and current studies suggest that obesity may be a risk factor for poor 
iron status (13–15,22,23). 
Coupled with activated macrophage initiation of IL-6, dietary sources can also 
stimulate IL-6 production and begin the inflammatory cascade (24–26).   Food related 
mechanisms that have been implicated in the promotion of the inflammatory phenotype 
center around increased expression of the protein complex, nuclear factor kappa-light-
chain-enhancer of activated B cells (ΝFκB) which is responsible for producing IL-6 
(27,28). For example, certain free fatty acids in the diet that act as non-immune ligands to 
activate toll-like receptor 4 (TLR4) have been shown to decrease the expression of 





upregulate the expression of NFκB (29).  Other dietary sources of inflammation are the 
advanced glycation end products of highly processed foods which have been found to 
increase oxidative stress and overexpression of the Receptor for Advanced Glycation End 
Products (RAGE) in enterocytes (30,31). These may all contribute to sustaining chronic 
inflammation and impairing iron status.    
However, individuals who regularly consume dietary antioxidants and anti-
inflammatory dietary components such as omega 3 fatty acids and certain flavonoids may 
demonstrate improved biomarkers of inflammation, reducing their future risk of chronic 
disease (32–34). Proposed mechanisms of action for anti-inflammatory effects of 
bioactive food components include improved composition of cell membranes, support 
during oxidative stress and through cell signaling pathways that can alter gene expression 
(35–37).  Although the exact mechanisms are still being actively investigated, qualitative 
studies and data from experiments in cell and animal models offer convincing evidence 
on the health benefits of including anti-inflammatory foods regularly in the diet (38–44).  
In order to most effectively evaluate the contribution of diet to inflammation, 
various dietary patterns and indexes have been developed. Among them is the Dietary 
Inflammatory Index (DII) which was designed to consider both proinflammatory and 
anti-inflammatory foods (45).  The DII is a validated predictive model for inflammatory 
markers and can be used with a variety of dietary assessment tools including 24h recalls, 





scores have been associated with higher IL-6 and higher CRP concentrations. However, 
no study has investigated its relationship with hepcidin and iron status.  
 
Main objective: The aim of this study was to determine the association between 
dietary intake and inflammation and how that influences circulating iron biomarkers in 
young adults. Circulating iron was assessed using serum iron and total iron binding 
capacity (TIBC). 
Specific Objectives 
1.  To compare circulating iron (serum iron and TIBC) and inflammatory 
biomarkers among study participants with normal weight, overweight and 
obesity. 
Hypothesis:  Subjects with higher BMI will have poorer circulating iron status 
biomarkers and higher CRP concentration 
2. To determine the association between the DII score and inflammation among 
study participants.  
Hypothesis: DII scores will be positively associated with CRP concentration 
among study participants. 
3.  To determine the association between the DII score and circulating iron 
biomarkers among study participants 
Hypothesis: Higher DII scores will be associated with poorer circulating iron 









The prevailing obesity epidemic in developed countries and that which is 
emerging in developing countries due to nutrition transition is alarming. While obesity is 
a well-known risk factor for various chronic diseases, recent studies have implicated 
obesity as a risk factor for poor micronutrient status (46). Particularly for iron, low-grade, 
chronic inflammation associated with obesity may increase concentrations of the iron 
regulatory protein hepcidin which may negatively influence levels of circulating and 
functional iron (47). Considering that diet may play a role in reducing inflammation, 
there is a need to investigate how dietary changes may indirectly influence iron status 
through its effect on inflammation among individuals with overweight and obesity. This 
review focuses on the importance of iron to human health, factors that influence iron 
status and the relationships between diet and inflammation, and methods for assessing the 
inflammatory effects of foods.  
Iron and Human Health 
Iron is required for sustaining human life and in maintaining healthful 
physiological functions.  Iron participates as a catalyst and promoter in enzymes and is a 
component of several globular proteins such as hemoglobin and myoglobin.  Primarily 





majority of body iron is contained in the heme protein, hemoglobin.   After hemoglobin 
ferritin, which stores iron as Fe2, accounts for the next largest supply of the body’s iron 
and is followed by myoglobin, with transferrin containing the least amount of iron, as 
ferric iron, (Fe3) (48).  In addition to the globin proteins, heme is a part of peroxidases 
and redox cytochrome enzymes.  Iron functions in ribonucleotide reductase and is a part 
of several iron sulfur proteins including aconitase of the TCA cycle and nucleotide 
binding protein (49).  In general, proper iron homeostasis is required for cognition, 
immunity and physical performance. 
Cognitive Development and Functioning 
Progress in iron research continues to support and further clarify how iron is a key 
factor for proper cognitive development and functioning, effective immunological 
responses, and sustaining physical competencies.   A novel study comparing the effects 
of iron deficiency (ID) on both white and gray matter in developing rats supports that 
even mild iron deficiencies may affect hypomyelination in hippocampal and cortical 
tissues.  Greminger et al. observed proximal shifts in apical dendrite branching and 
significant decreases in basal dendrite length and branching with 50% fewer interactions 
in the Fe deplete diet group compared to the Fe diet group (50).  In a prospective cohort 
study using cord blood, Amin et al. compared the auditory brainstem evoked response of 
infants born full term.  Results of the study showed significantly prolonged interpeak 
latencies in the infants whose cord blood serum ferritin levels were between 11-75 ng/ml 





increasing pace of studies on the associations of iron status and attention deficit disorders, 
pointing to the effects of iron deficiency (ID) on frontal lobe functioning(52).  A study of 
women of reproductive age adds support to previous findings that even marginal declines 
in iron status of non-anemic women are correlated with reduced proficiency in 
completing executive functioning tasks such as sustained attention, learning and shifting, 
inhibitory control, working memory and problem solving (53).  Results of this study are 
the first to suggest that even marginal increments in ferritin and total body iron are 
related to improvements in problem solving and planning tasks among non-anemic iron 
deficient women of reproductive age. 
Immunity 
Current research on the relationship between iron status and immunological 
response includes studies on asthma and lung function, improved immune function 
studies, and how iron deficiency may be protective against malaria (54–58).  Using data 
from the 2007-2010 survey cycles of the National Health and Nutrition Examination 
Survey (NHANES), Brigham et al. found that among women 20-49 years of age, those 
with the highest ferritin values experienced an average reduced risk of lifetime asthma, 
and current asthma by 31% and 53% respectively (55).  In addition to ferritin, the iron 
binding glycoprotein lactoferrin (LF) which is very similar in structure to transferrin, is 
another important iron-bound molecule that supports immunity (56).  LF is expressed by 
epithelial tissue and can be taken in exogenously from human breast milk and other 





shown in a number of in vivo and in vitro studies (54).  The ability of LF to effect 
improvements in immune functioning in older adults was observed in an RCT of people 
ages 66-87 receiving lactoferrin supplementation.  The experimental group in the study 
experienced significant increases in neutrophil phagocytic capacity, natural killer cell 
cytotoxicity and limited improvement in lymphocyte subset ratios (57).    
 Interventions with iron supplementation have also shown improvements in 
immune functioning. In a case control study on the effects of iron deficiency on the 
humoral and cell mediated immunity of children, lower CD4 lymphocyte levels as well as 
impaired CD4:CD8 ratios were improved following 3 months of iron supplementation 
(6mg/kg/day elemental iron) preceded by treatment for parasitic infections 
(59).  However, supplementing with iron in cases of unresolved parasitic infections has 
been shown to negatively affect outcomes (58,60).  
Optimizing Physical Performance and Aerobic Capacity 
Optimal physical functioning and aerobic capacity are also known to rely on 
adequate functional iron supplies.  While this is a well-established principle, current areas 
of research are expanding the breadth of the literature to include non-anemic iron 
deficiencies, effects of intense physical training on individuals with iron deficiencies, and 
the benefits of iron supplementation on aerobic and strength training performance among 
women, including athletes, women in the military and recreationally active women (61–





supplementation in men and women who may have non-anemic iron deficiencies or who 
engage in moderate to high intensity activities on a regular basis. 
Factors Affecting Iron Status 
Iron Intake and Absorption 
Although the majority of body iron supplies are maintained by recycling during 
erythropoiesis, enough iron must be taken in by the diet to replenish the 1-2 mg lost daily 
(49).   Recommended daily intakes for iron are 8 mg for adult men, 18 mg for adult 
women and 27 mg for pregnant and lactating women (66), however Armah et al. have 
suggested that these values may need to be adjusted upwards to be able to meet 
physiological iron requirements (67).  Humans acquire iron through consumption of 
heme from myoglobin or hemoglobin in meats and inorganic iron of plant foods, 
synthetically fortified foods or of animal tissues.  While a higher percentage of iron is 
absorbed from heme sources (68), most of the dietary iron consumed is from iron 
fortified cereals and breads due to the widespread consumption of both food products 
(69).    
It is well known that iron from heme sources is taken up and utilized more 
efficiently than non-heme sources.  This is based primarily on the consensus that heme 
moves into the enterocytes of the brush border membrane (BBM) intact, unencumbered 
by competition for transporters or through loss due to “anti-nutrient” activity of oxalates 
and phytates.  Evidence continues to support this assertion and points to endocytosis or 





modes of absorption at the BBM (70,71).  A study of piglets with iron deficiency anemia 
(IDA) showed a four-fold increased expression of Slc46a1, the gene coding for HCP1 in 
piglets given oral supplementation of bovine hemoglobin compared to both control 
piglets given parenteral Fe and to piglets receiving intramuscular injections of the 
conventional treatment of iron dextran.  Results also showed that piglets receiving oral 
heme supplementation had more than a three-fold increase in Fpn mRNA expression on 
the basolateral membrane (BLM) of duodenal enterocytes compared to both control and 
to iron dextran injected piglets.  Furthermore, hepcidin mRNA expression in the livers 
and plasma of the heme and control piglets remained consistently low throughout the 
study compared to increased hepcidin levels in iron dextran injected pigs, which began to 
increase significantly at day fourteen of the study and continued to do so until the study’s 
conclusion (72).   
Following digestion, iron from vegetable sources is transferred into the cellular 
environment from the intestinal lumen by a divalent metal transporter (DMT1).  Control 
of iron absorption by enterocytes depends both on systemic factors, local transcription of 
HIF-2a, and by posttranscriptional mechanisms of the iron regulatory protein and iron 
response element systems (71).  Since ferric iron (Fe3) must be reduced prior to transport 
by DMT1, its absorption can be increased by the presence of ascorbic acid which reduces 
it to ferrous iron (Fe2), allowing it to bypass the ferric reductase enzyme, duodenal 
cytochrome b (Dcytb) present in the lumen.   Other dietary components that enhance non-





Alternatively, other digested compounds such as phytates and oxalates may bind with 
iron in the lumen causing it to pass unabsorbed and unutilized by the body.  Similarly, 
other metals, like calcium, cadmium, cobalt, magnesium and zinc in excess, may compete 
with iron for DMT1, reducing the amount of iron absorbed and cause it to pass unutilized 
by the body (73,74).  Recent ex vivo experiments have demonstrated that hepcidin too 
can reduce absorption of dietary iron by downregulating mRNA levels of DMT1 and 
Dcytb (75). 
Because vegetarians do not include heme or animal protein in the diet, it is 
estimated that only between 5% and 12% of iron in their diet is absorbed (76).  For this 
reason, the United States Institute of Medicine recommends that vegetarians consume 1.8 
times more iron compared to those consuming a mixed Western diet (66). Proper meal 
planning that accommodates optimal iron absorption via nutrient to nutrient interactions 
are essential for maintaining proper iron status.  Researchers Ghatpande et al. (77) 
studied the relationship between iron status, inflammation and the dietary data of 85 
adolescent girls in India, a nation whose population relies heavily on non-heme iron from 
plant-based diets. Among the subjects, 28% were anemic and 66% were ID. Their 
primary goal was to examine the relationship between ferritin, serum iron, hepcidin, 
TNFα and B12.  Overall the study reported that regular consumption of vitamin C rich 
fruits had significant effects on iron status and that B12 was negatively associated with 
TNFα.  Amla, a fruit very rich in vitamin C, was regularly included in the diets of girls 





ferritin was observed.  Among the girls who ate guava regularly, B12 and ferritin 
associations were significant.  An interesting finding involved consumption of fetid 
cassia, (fruits from a tree that grows in ruined buildings) which is a traditional treatment 
for ringworm.  Subjects who did not eat fetid cassia were at a 3.9 times increased risk of 
low serum iron.     
Additionally, sufficient intake of B12 either from supplements or fish sources 
must also be made available for effective erythropoiesis to protect against anemia.   The 
benefits of a combined folic acid (FA), B12 and iron supplementation were shown in a 
supervised RCT among 446 IDA adolescent girls living in a very low socioeconomic 
section of New Delhi.  In the study, Bensal et al. (78) showed that while both the FA and 
B12 +FA iron supplements reduced the prevalence of iron deficiency anemia (IDA) 
among the group, the B12 + FA iron supplement reduced IDA among the subjects more 
significantly as well as improved ferritin status compared to the FA+iron supplement.   
Physiological Needs 
The higher incidences of ID and IDA among pregnant women, premenopausal 
women, and children reflect the increased physiological demands for iron in these 
demographics (79–81).  Pregnant women require more dietary iron for increases in blood 
volume and supplies to the fetus, premenopausal women with menorrhagia need more 
iron for replacing excessive blood losses and children require more iron for the changes 
in blood volume and hemoglobin concentrations (66).  Also, hypoxia is a physiological 





erythropoietin will enhance intestinal iron absorption and dietary iron intake will 
subsequently have a greater impact on iron status than in individuals without higher 
physiological needs (82).   
  High altitudes, severe blood loss, low erythrocyte production and adipose tissue 
hypoxia will limit oxygen supplies for red blood cell production.  When these changes 
are sensed by baroreceptors in nephrons, EPO transcription is upregulated in the in 
peritubular fibroblasts in the renal cortex via binding of hypoxia inducible factor (HIF) 
heterodimers to hypoxia responsive element (HRE) of the EPO gene (83).  The increases 
in EPO suppresses hepcidin via upregulation of the erythroid, erythroferrone (ERFE) and 
ultimately causes increases in dietary absorption to correct the deficiency (84,85).  
Infection 
Intestinal parasites are another gastrointestinal disorder that can impair iron 
status.  While most common in developing nations and among children, intestinal 
parasites continue to be a major cause of anemia globally.  Parasitic infestations on their 
own, or in combination with an already poor diet quality can worsen iron status.  An 
increased prevalence of the intestinal parasite Giardia, a major cause of diarrhea (86), is 
suspected of increasing IDA, especially among school children in both developed and 
developing countries (87).  Hussein et al. (87) conducted an analysis of 650 stool samples 
from pre-school Egyptian children presenting with IDA to determine the association of 
Giardia infection types with IDA.  While several intestinal parasites were discovered, 88 





assemblages A were associated with 90.9% of the IDA cases and Giardia assemblage B 
with only 9.1% of the cases.  Helicobacter pylori (H. pylori) which is also found in 
populations around the world is more prevalent in older people with recent studies 
showing that H.pylori may be impacting vitamin B12 status in addition to reduced blood 
iron (88,89).  A case control study of younger hospitalized patients hospitalized with 
H.pylori showed that the decreases in B12 and iron levels were improved to near normal 
levels upon treatment for the infection (90).  Lastly, studies on the effects of colonic 
microbiota are demonstrating a viable link between an organism’s microbiome and 
expression of hepcidin (91).  
Inflammation 
Hepcidin, an antimicrobial peptide produced mainly by the liver, helps to 
maintain safe supplies of functional iron by facilitating the sequestration of circulating 
iron into storage as ferritin if liver iron stores are high or whenever inflammation is 
triggered by the innate immune system.  This inflammation cascade is initiated at the site 
of infection or injury by neutrophils which secrete interleukin-1 (IL-1) to recruit 
macrophages that in turn secrete interleukin-6 (IL-6) that signals the liver to produce and 
release hepcidin (92,93). As hepcidin circulates in the body, it prevents iron from 
entering the bloodstream by binding to and disabling the transmembrane iron exporter 
protein, ferroportin (Fpn) which is found primarily on hepatocytes, macrophages and 
enterocytes.  While this effectively limits the efflux of iron from these cells and into 





established.  However, in a recent ex vivo study, it is reported that hepcidin exposure 
elicited changes in human duodenal mucosa that modulate several steps of the iron 
absorption process, including a reduction of dietary iron by Dcytb, its uptake by 
enterocytes through DMT1, the mucosal uptake of heme iron by HCP1, and enterocyte 
iron release to plasma by Fpn1 in conjunction with hephaestin through transcriptional 
change (89).   Conversely, when iron is required for the formation of red blood cells, 
erythroferrone (ERFE) is produced and hepcidin is suppressed (94). The impact of 
inflammation on iron status is seen in conditions such as autoimmune disorders, and 
inflammatory bowel disease in which high hepcidin concentration may predispose 
patients to anemia of inflammation (12).  
Foods and Inflammation 
It is well recognized that foods can significantly impact inflammatory status 
through a variety of mechanisms.  Some examples of foods and food components that 
have been linked to inflammation are discussed below.  
 Fatty Acids 
Certain fatty acids have been shown to directly influence proinflammatory 
cytokines via the arachidonic pathway and polyphenols have been shown to indirectly 
affect inflammation by reducing conversion of arachidonic acid to eicosanoids, 
modulating nitric oxide production (NOS) and downregulating the expression of genes 
associated with inflammatory signaling pathways, scavenging of reactive oxygen species 





98).  Both monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA)s 
are known to be healthful fats and are recommended over saturated fats which have been 
shown to have acute inflammatory effects (95–98).  
The potential health benefits of MUFAs and PUFAs were highlighted in the large-
scale intervention study, PREDIMED, which studied how three diets containing different 
fat profiles affected the risk for CVD among high risk patients.  An extra virgin olive oil 
(EVOO; MUFA diet) diet, a PUFA rich diet with nuts (walnuts, almonds and hazelnuts), 
and a low-fat diet fashioned by the American Heart Association recommendations, were 
studied.  All three diets included recommendations for high consumption of fruits and 
vegetables.  A number of sub studies have emerged comparing these three different diets 
with plasma concentrations of inflammatory cytokines in the blood samples.   
Casas et al. (38) investigated the anti-inflammatory effects of MUFA and PUFA 
diets in a subcohort of 164 PREDIMED participants with atherosclerosis over the course 
of 12 months.   C-reactive protein and IL-6 were reduced by 45% and 35% and 95% and 
90% in the MUFA and PUFA diet respectively (P<0.05).  In a long-term study of an 
elderly cohort, the same researchers found that at 3 and 5-year test points, both the 
MUFA and PUFA rich diet showed a significant reduction of IL-6, IL-8, MCP-1, and 
MIP-1β (P<0.05) compared to subjects following the low-fat diet recommendations.  The 
MUFA rich diet stood out further in that it demonstrated improvements in TNF-α, as well 





The Canola Oil Multisite Intervention Trial (COMIT) compared the effects of 
three different Canola oils and two safflower blended oils on the biomarkers of CVD risk 
which included CRP and IL-6.  The Canola oils were designed to have higher 
percentages of omega-3 fatty acids while containing the same amount of protein, 
carbohydrate, lipid, saturated fat, fiber and cholesterol percentages whereas the safflower 
blended oil diets contained higher omega 6 fatty acids than the Canola oils.  A primary 
objective of the study was to better identify the effects of oils containing various amounts 
of alpha linolenic acid (ALA). Linoleic acid (LA) Oleic acid (OA) and docosahexaenoic 
acid DHA outside of the Mediterranean diet context (99).  Since only endpoint 
differences were reported it is unknown how CRP levels changed from baseline among 
the subjects.  However, endpoint data showed that CRP was significantly lower in the 
Canola oil diet compared to the corn/safflower blend control diet which had a 
disproportionately higher omega 6 to omega 3 ratio.  
Another interventional study that included a comparison of the anti-inflammatory 
effects of an unprocessed oil with a processed oil demonstrated the anti-inflammatory 
benefits of EVOO compared to refined olive oil (ROO).  In the study, HIV patients who 
consumed an EVOO diet had significantly lower average CRP levels compared to those 
patients consuming ROO diet, which contained no polyphenols (100).  These 
observations were attributed to the presence of polyphenols in reducing the effects of 
lipid oxidation, thereby protecting the tissues (epithelia) from oxidative stress and injury 






Polyphenols are a group of plant-based chemicals that have at least one phenol 
group. They are divided into two main groups, phenolic acids of red fruits, black 
radishes, onions, coffees, cereals and spices and the spectrum of flavonoids, which are 
found in soy (isoflavones),  in berries (anthocyanidins), in herbs (flavones), in broccoli, 
kale and tea (flavonols), flavanones found in citrus fruits and juices (flavanones).  Cell 
studies, mouse studies and human studies all demonstrate the anti-inflammatory effect of 
a polyphenol rich diet (PPD) (101,102). 
Examples of commonly consumed polyphenol rich foods include coffee and tea. 
Both beverages contain an array of polyphenols.  Chlorogenic acid, 5-caffeoylquinic acid 
(5-CQA), which is contained in the coffee bean, is consequently one of the most 
commonly consumed phenolic acids in the world.   Green tea is high in flavon-3-ols and 
black tea which is fermented, also contains oligimeric flavonoids.  Both coffee and tea 
contain the flavonol, quercitin (103).  A number of cell culture, animal and human studies 
have been performed and demonstrate the anti-inflammatory effects of their bioactive 
components (103–114). Studies have also shown anti-inflammatory benefits of 
isoflavones which are primarily consumed in beans (115–122) (116–123).  
Influences of Western Style Diets 
In contrast to the anti-inflammatory effects of monounsaturated fatty acids and 
polyphenols found in more traditional diets, injurious metabolic and bioactive byproducts 





response both acutely and in chronic fashion.  These diets are characterized by being 
highly caloric, highly processed and high in manufactured, refined oils (123).  Recently, 
Christ et al. (124) demonstrated how exposure to a Western diet both induces the 
systemic inflammatory response and evokes long term phenotypic changes of an 
enhanced immune response in myeloid cells regardless of dietary change.  This research 
has revealed the nucleotide-binding oligomerization domain receptor protein 3 (NLRP3) 
inflammasome as the central mediator of diet induced systemic inflammation and how 
myeloid precursor reprogramming are involved in the long-term immunomodulatory 
effects of inflammatory diets.  Both are important additions to the established body of 
research that describes more acute inflammatory responses (125–129) to components of 
food and may lead to a broader understanding of how food borne “sterile” inflammation 
may impose a persisting, heightened trained-immune response of metabolic pathways.   
Added Sugars 
The added sugars in Western diets include fructose, sucrose, and high fructose 
corn syrup.  Ample evidence supports a role for added sugars in the promotion of chronic 
disease. (130–134) including a number of studies showing associations between 
biomarkers of inflammation and increased consumption of sugar sweetened beverages 
(SSB) (135–138). 
In a cross-sectional observational study of 9678 participants in the population-
based Fenland Study, O’Connor et al. (135) studied how free sugars from beverages, fruit 





sugars from solids with naturally occurring sugars.   The results of the analyses revealed 
that intakes of free sugars from liquids and from sugars added to liquids like coffee and 
tea but not sugars from foods, were significantly associated with increased CRP among 
subjects in the highest quintile compared to the lowest quintile of consumption (124). 
In a mouse study, seven months of either 15% glucose or 15% fructose showed 
higher accumulations of triglycerides in gastrocnemius muscle of both groups compared 
to standard chow controls but higher intramyocellular lipids and associated IL-6 in 
fructose group compared to glucose group (139). More recently, Kovacevic et al. (140), 
studied female Wistar rats fed either standard chow with water (n=9) or standard chow 
with 10% fructose solution for 9w.  Results showed NFK-β to be higher in the cytosols 
and nucleosols of VAT of fructose treated rats compared to water with chow treated rats 
and increased mRNA levels of both NFK-β and Il-1B by 25% and 40% respectively 
among fructose treated rats.  Together these findings reveal how added sugars induce 
inflammatory signaling and cytokine production by way of increased oxidative stress in 
female rats. 
A two-week crossover RCT by Raatz et al. (141), examined the metabolic effects 
of chronic intakes of three sources of sugars (honey, sucrose and high fructose corn 
syrup) in both glucose tolerant (GT) and glucose intolerant (IGT) subjects 
(n=60).   While triglyceride concentrations were significantly increased in all subjects 
from baseline, only IGT subjects had significant associations of CRP and glycemic 





processing similar results found in exposures to the different sweeteners may indicate that 
the heat treatment of the sugars may have caused these effects.  Also, the treatment 
period of only two weeks, along with the relatively low amount (50g) of sweetener may 
not have been enough added sugar to evoke a metabolic inflammatory effect in 
normoglycemic individuals.  Concentrations of CRP observed in the GT group were 
within the normal range (<3.0 mg/L).  Higher body weight among the IGT group may 
have been the factor behind the status × treatment interaction found in the study results 
(P= 0.03). 
The inflammatory effects of low to moderate intakes of SSB were first 
demonstrated by Aeberli et al.(142), in a clinical trial evaluating the effects of beverages 
containing different sweeteners on metabolic factors in healthy young men. In the study, 
six different SSB interventions of varying concentrations of fructose, glucose or sucrose 
were given to normal weight males (n=29) aged 19-25y that did not take regular 
medications or consume more than 60g SSB daily.   Although differences were observed 
among the sugars on LDL size, all the sugars had a similar effect of increased fasting 
glucose and more than twice the CRP concentrations compared to baseline.  However, a 
similar RCT in Hispanic adolescents with NAFLD that were exposed to either glucose or 
fructose beverages, reported that CRP was reduced by nearly half in glucose beverage 







Dietary Advanced Glycation End Products 
In addition to being high in added sugars, western style diets are also high in 
advanced glycation end products that result from the non-enzymatic Maillard reaction, a 
common food preparation and processing technique that is widely used in the 
manufacturing of ultra-processed convenience foods that accommodate modern 
lifestyles.  Dietary advanced glycation end products (dAGEs) are produced when 
carbonyl groups of non-reducing sugars interact with free amino acid groups of 
proteins.  Intermediate aldehydes and dicarbonyls are first produced and then react with 
other biomolecules, to form a group of heterogeneous, “end product” compounds (144). 
Even as much as the cooking process enhances the flavor, aroma, and appearance of 
foods, these end products which are found to a great degree in French fries, potato chips, 
baked goods and pasteurized dairy are now believed to contribute to the inflammation 
associated with chronic and autoimmune diseases (89,145–147) .  The most commonly 
studied dAGEs include carboxylethyl-L-lysine (CEL), carboxymethyl-L-lysine (CML), 
and hydro-methyl-imidazolon (MG-H1).  Several observational studies have reported 
associations between dAGES with increased inflammation and human interventions have 
demonstrated that reduced inflammatory markers are associated with dAGEs restricted 
diets (27,148–151). 
Researchers Di Pino et al., have conducted both observational and interventional 
studies investigating the health risks of dAGE exposures in subjects with type 2 diabetes 





reductions in CRP compared to standard dAGE diets (150).  In their cross-sectional study 
(n=85), the researchers reported that subjects consuming diets containing more than 
15,000 kU/dAGEs/day had significantly higher CRP than subjects whose diets were 
below 15,000 kU (149).  Similar associations between dAGE consumption and serum 
AGEs (sAGEs) were found by Uribarri et al., (27) in an earlier prospective cohort study 
of subjects with obesity and risk for metabolic syndrome (MS).   
While human studies are still limited, numerous animal models offer insights into 
dAGEs role in inflammation.  The pro-inflammatory effects of CML, and associated 
renal damage were reported in a study of intrauterine growth retardation piglets 
(IUGR)(n=8) that were fed either low heated (LHF) or high heated infant formulas 
(HHF).  In the study, Elmhiri et al. (152), observed that piglets receiving HHF had higher 
mRNA expression and protein activation of NF-𝛋B by 33% and 120% respectively.   
Recently, a mouse model expressing firefly luciferase under control of NF𝛋-B regulation 
was used to investigate systemic activation of the secondary messenger pathway, NF-𝛋B 
from AGE modified foods.  In their experiments, NF𝛋-B luciferase activity was 
significantly higher in animals fed AGE treated bovine serum albumin (BSA) compared 
to both BSA fed animals and to positive controls with the highest luciferase activity 
found in the gut at 6-8h post feedings (153).  
Increased intakes of dAGEs add to the pool of endogenous AGEs which are 
produced when proteins such as albumin or globulins react non-enzymatically with 





systemic AGEs which is commonly observed in diabetes, during aging and from diets 
high in added sugars (148).   Circulating AGEs from either source (endogenous or diet 
derived) can be bound by the advanced glycation end receptor 1 (AGER1) or by the 
receptor for advanced glycation end products (RAGE).  AGER1 binding of AGEs 
reduces their intracellular and extracellular presence and therefore reduces oxidative 
stress both intracellularly and among the tissues.  RAGE binding of AGEs however, 
activates several signaling pathways including NF-κB, resulting in a proinflammatory 
effect which mediates increases in both transmembrane and soluble RAGE which is 
found in the sera (14).  Most importantly the link between RAGE and the NLRP3 
inflammasome was established by Yeh et al., (154) in BALBc mice experiments, who 
demonstrated that dAGEs mediate activation of NLRP3 secretion of Ilβ-1 via conversion 
of pro-caspase to caspase. 
Inflammatory Diet Indexes 
Approaches that reflect the overall health potential of the diet are currently being 
used to describe population and individual diet patterns.  Mediterranean Diet Patterns, 
Anti-Inflammatory Patterns and the USDA promoted, Healthy US Dietary Pattern are 
considered more useful in promoting healthful eating, capturing multiple dietary factors, 
and offering more comprehensive assessments of diet quality while accounting for the 
complex interactions of foods and nutrients.  Researchers have also developed indexes 
that can be used to assess the inflammatory/anti-inflammatory potential of diets.  The 





(DII) are two examples of such indexes.  Both tools were created to quantify the overall 
effects of the inflammatory foods in an individual’s diet in mediating inflammation 
related diseases and can be used by researchers, public policy makers and clinicians 
helping patients reduce risk of inflammation related diseases.   
Empirical Dietary Inflammatory Pattern Index 
The development of the EDIP was driven by the hypothesis that reduced rank 
regression analysis (RRR) of dietary data from the Nurses’ Health Study (NHS) would be 
predictive of inflammatory markers (155). The developers believed that an “a posteriori” 
statistical method would better portray the inflammatory effect of foods by using the 
response variables to derive the dietary patterns than would an indexed or an “a priori” 
pattern in which scores are derived from current scientific knowledge. Additionally, the 
EDII was construct validated in two independent samples of women and men in the NHS. 
Instead of including single nutrients in inflammatory scoring methodology, the 
EDII score is based on 39 food groups previously defined in the 1986 and 1990 FFQs of 
the NHS.  First, a mean daily intake of the food groups was calculated and then RRR was 
applied to derive a dietary pattern associated with CRP, IL-6 and TNFαR2.  The 
researchers found 18 food groups as significantly contributing to the inflammatory 
markers.  Intakes of white meat fish, tomatoes, processed meats, high and low energy 
beverages, vegetables (other than green leafy or yellow), red meat, refined grains and 
organ meats were positively associated with inflammatory markers.  Curiously, pizza, 





well as fruit juices which are high energy beverages, were inversely associated with 
inflammatory markers.  The relative validity of the EDIP score was evaluated in 2 
independent cohorts of health professionals: the Nurses’ Health Study (NHS)-II and 
Health Professionals Follow-up Study (HPFS) (156).  Using data from the Women's 
Health Initiative (WHI) baseline FFQ, researchers confirmed the association of the EDIP 
score with markers of inflammation in a more racially diverse population of older 
women.  While this tool may be useful in studies that rely on these same food groups and 
that do not have access to nutrient data analysis, it seems limited in its scope to accurately 
portray the inflammatory load in diets other than US diets. 
The Dietary Inflammatory Index 
 The DII also quantifies the overall effects of the inflammatory foods in the 
diet.  Originally, the index was developed from 929 research studies and validated in 
2009 with subjects’ data from the Seasonal Variation of Blood Cholesterol Study 
(SEASONS) (45).  The DII was developed further by the Cancer Prevention and Control 
Program at the University of South Carolina in 2011-2012.  The researchers enhanced the 
scoring algorithm of the original DII with the data of more recent and a much larger 
number (1,943) of articles.  In addition to increasing the robustness of the data collected, 
the scoring system was improved to include differential inflammatory effects reported 
among various foods and is standardized based on human consumption.  Data from 
eleven regional populations are also factored into the scoring to provide comparison 





regionally reliable.  Lastly, the DII can be used with a variety of dietary data.  Scoring is 
reported as a percentile of maximum inflammatory effects of the data from each of the 45 
food parameters which include macronutrients, micronutrients, flavonoids, and some 
herbs. 
Since its redesign in 2012 the DII has been used to assess the inflammatory effect 
of foods in several studies, especially among populations afflicted with colon cancer 
(125). It has proven to be predictive of gastric and breast cancers, cardiovascular disease 
CVD, and poor diets (157–162). Its methodology was construct validated with data from 
NHANES, the SEASONS study and the WHI (163–166).  It has also been validated 
among African Americans (167), post-menopausal women(166), and police 
officers(168).  Recently the same researchers developed a children’s DII (C-DII).  Up 
until now, no study has investigated the interrelationships among DII scores 









   
Introduction 
  
Poor iron status in obesity is reflected by an iron profile of which hypoferremia is 
often, but not always paired with hyperferritinemia (22,169–172).  These effects, which 
have been observed in iron studies among subjects with obesity are believed to be the 
result of increased hepcidin signaling.  The hepatocyte response in obesity mirrors that 
which is seen during the acute phase response in which IL-6 signaling from tissues causes 
increased hepcidin release from the liver (93,160,173–176). However, in obesity and 
other chronic inflammatory diseases, the factors fueling the hepatic response remain 
uncorrected, obstructing hepcidin’s original purpose, and subsequently healthy iron 
metabolism becomes impaired. 
It is well established that the relationship between inflammation and obesity is 
rooted in a mechanism of persisting adipose plasticity that promotes an inflammatory 
cascade via increased IL-6 signaling. Several studies have described parallel cytokine 
messaging from both hypertrophic adipocytes and neighboring hypoxic tissues 
supporting adipocytokine and cytokine release and increased macrophage infiltration into 
omental fat depots (174,177,178).  Overproduction of TNF-α, IL-1, IL-6, and MCP-1 





like receptor-4 (TLR-4) due to the lipotoxic effects of chronically elevated free fatty 
acids (FFAs) in obesity.  Together these create a positive feedback paracrine loop of 
deregulated TNF-α synthesis that promotes and supports persistent systemic 
inflammation. 
Similarly, dietary sources can also stimulate IL-6 production via the immune 
system and therefore may also contribute to poor iron status by supporting increased 
release of hepcidin via the inflammatory cascade (124,125,179,180).  Food components, 
such as free fatty acids, added sugars and advanced glycation end products act as non-
immunity mediated ligands for TLR-4, NLRP-3 and other cell surface receptors that 
mediate induction of nuclear factor kappa B (ΝFκB).  Conversely, diets high in foods 
with antioxidant and anti-inflammatory properties including polyphenols, vitamin C and 
Omega 3 fatty acids for example have been associated with reduced risk of chronic 
inflammation (42,44,77).  Thus, studying associations between diet mediated 
inflammation and iron status may offer insight into modifying the inflammatory cascade 
via food intake strategies. 
In order to optimally assess the overall effect of dietary inflammation, the dietary 
inflammatory index (DII) was designed to consider both proinflammatory and anti-
inflammatory foods.  As a validated predictor of IL-6, and the well-known biomarker of 
systemic inflammation, CRP among a number of populations, the DII may be calculated 
using a variety of dietary assessment tools including 24h recalls, food frequency 





inflammatory diets impair iron status independent of BMI.   We hypothesized that DII 
scores will be positively associated with CRP concentration, and that higher DII scores 
will be associated with poorer circulating iron biomarkers. 
Methods 
Study Population 
Data from two cross-sectional studies of the same design namely the Diet and 
Inflammation Study (DI study) and the Selenium and Inflammation Study (SI study) were 
used for this analysis(181,182). The DI study was conducted in Spring 2017 to 
investigate the relationships among diet, hepcidin and iron status. Subjects recruited for 
this study were those within the age range of 18 to 49 years who were non-pregnant, non-
lactating, and non-smoking. Additionally, they were not to have donated blood in the past 
two months, must not be taking vitamin and mineral supplements, and must have a BMI 
within the range of 25.0 to 40 kg/m2.   A total of 147 subjects responded to the mass e-
mail and 67 subjects were came for screening.  Twenty-two participants were ineligible 
due to BMI, two were excluded due to supplements or medications, and two did not 
complete blood draw.  In total, 39 participants completed the DI study. Dietary intake, 
and anthropometric (height and weight) measurements were conducted on each subject. 
Fasting venous blood samples were collected to measure concentrations of iron status and 
inflammatory markers. The SI study on the other hand was conducted in Spring 2018 to 
investigate the associations among selenium status, hepcidin concentration and iron status 





controls.  Similar to the DI study, subjects were included if they were non-pregnant, non-
lactating, non-smoking, not using vitamin and mineral supplements and had not donated 
blood in the past two months. However, the BMI criteria for inclusion in the SI study was 
≥18.5 kg/m2.  In addition to collecting dietary, anthropometric and biochemical markers, 
the SI study also collected additional anthropometric variables such as body fat, visceral 
fat, and muscle mass, and also measured plasma selenium concentration, and other 
biomarkers of selenium status among subjects.  A total of 129 subjects responded to mass 
e-mail and 66 came for screening in the SI study of which two opted out for personal 
reasons, one did not meet BMI criteria, and one subject did not complete the blood draw.  
In total, 59 subjects were included in that study.  Both studies were conducted at the 
Cemala Foundation Human Nutrition Research Laboratories at the Nutrition Department 
of The University of North Carolina at Greensboro (UNCG). The study protocols were 
approved by the Institutional Review Board of UNCG.  Summary of subject recruitment 
and inclusion in the two studies is shown in Figure 1.  In each of the studies, informed 
written consent was obtained at screening from every subject before recruitment.  After 
signing the consent form, each participant was requested to complete a screening form 
requiring information such as demography, vitamin and mineral supplement use, medical 
history and pregnancy status. Height and weight measurements were also done at 







Figure 1. Subject Recruitment 
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For each of the two studies, qualified participants were provided with a dietary 
record form, food frequency questionnaire, and a weighing scale and were required to 
record all foods consumed on three non-consecutive days of which two were weekdays 
and one was a weekend day. At the follow-up study visit, anthropometric measurements 
were repeated, a 10h fasted venous blood (approximately 30 ml) was collected and 
participants submitted their completed three-day dietary records. The dietary records and 
food frequency questionnaires were reviewed with each participant by trained research 
assistants.  
         Dietary data from the three-day dietary records were analyzed into nutrients using 
the Nutrition Data System for Research (University of Minnesota, MN, USA) and used in 
calculating the DII scores. Up to 45 food components can be used for calculating DII 
scores.  Thirty of these were available from the NDSR data and were used in the analyses 
of this study (Table 1).  These included: fiber, vitamin B6, folic Acid, niacin, riboflavin, 
thiamin, beta carotene, vitamin A, vitamin D, vitamin E, vitamin C, caffeine, alcohol, 
selenium, magnesium, zinc, isoflavones, MUFA, Omega 3, Omega 6, PUFA, total fat, 
trans fat, saturated fat, iron, carbohydrate, protein, cholesterol, Energy, vitamin B12. The 
first twenty-one components were considered anti-inflammatory and the remaining 
considered inflammatory. The DII calculations were done at the Cancer Prevention and 





For each participant, some of the fasted blood samples were sent to LabCorp 
(Burlington, NC) after processing for the measurement of hemoglobin, iron saturation, 
serum iron, total iron binding capacity (TIBC), serum ferritin and C-reactive protein 
concentration (CRP). The remaining were stored at -80 oC at UNCG for the measurement 
of hepcidin concentration at the end of each study.  Hepcidin was analyzed using ELISA 
assay kit from Peninsula Laboratories International (San Carlos, CA, USA).  
 
Table 1.  Food Components of DII Scoring Algorithm 
 

















































Subjects were categorized has having normal weight (18.5-24.9 kg/m2), overweight (25-





categorize the DII scores into either pro inflammatory or anti-inflammatory diet group, 
we used cluster analysis. 
Statistical Methods 
Statistical analyses were done using the R statistical software (183).. DII scores 
were treated both as a continuous variable and as a categorical variable for the purpose of 
investigating all possible relationships between the DII and the primary outcome 
variables which were serum iron, TIBC, hepcidin concentration and CRP concentration.  
To categorize the DII score into either a pro inflammatory or anti-inflammatory diet 
group, we chose cluster analysis with only two groups to ensure adequate sample size for 
each group.  Percentages were reported for categorical variables such as sex, ethnicity 
and BMI categories. Hepcidin, ferritin, and transferrin saturation values were used for 
post hoc analyses.    The means and standard error of mean (SEM) were reported for the 
continuous variables such as age, BMI, serum iron, hemoglobin, TIBC, transferrin 
saturation and for the concentrations of ferritin, hepcidin, and CRP.   Skewed variables 
were log transformed and the geometric means were reported. Fisher’s exact test and 
ANOVA were used to compare background characteristics.  Where ANOVS showed 
statistical significance, Tukey’s HSD was used for multiple comparison.  Linear 
regression analysis was used to determine the association among the DII as an 
independent variable with CRP, hepcidin concentration, serum iron and TIBC.  All 





meat, fish and poultry intake where necessary since iron intake was considered pro-
inflammatory in the DII calculations. Statistical significance was set at P ≤ 0.05. 
Results 
Background Characteristics of Subjects  
Participant background characteristics grouped by BMI category are displayed in 
(Table 2).  The overall mean age was 21.0 ± 0.4y and the majority of the subjects (72 of 
the 98) were female.  Despite higher female representation, the distribution of both sexes 
among BMI categories was not significantly different. (p=0.6).  Similarly, there was no 
significant association between BMI category and ethnicity (p = 0.7). BMI categories 
were also well represented with 29% of subjects having normal weight, 40% having 
overweight and 32% having obesity status (total percentage not equal to 100 due to 
rounding).   
 
Table 2. Background Characteristics According to BMI 
   
 












Age (y) 21.2±0.4 21.4±0.7 21.8±0.6 21±0.4 0.8 
Sex1     
0.6 
Male 8 (8.16%) 9 (9.18%) 10 (10.20%) 27 (27.55%) 





Ethnicity1     0.7 
Hispanic 3 (3.06%) 4 (4.08%) 4 (4.08%) 11 (11.22%) 
NH White 14 (14.29%) 11 (11.22%) 13 (13.27%) 38 (38.78%) 
NH Black 6 (6.12%) 13 (12.27%) 16 (16.33%) 35 (35.71%) 
Other 5 (5.10%) 3 (3.06%) 6 (6.12%) 14 (14.29%) 
BMI1, 
kg/m2 
22.5±0.3a 27.0±0.24b 34.9±0.50c 28.±0.5 
<0.0001 
Values are 1means ± SEM , 2 are n (%) or 3geometric means (geometric mean – SEM, 
geometric mean + SEM)           
 
 Nutrient Intakes and DII Scores among Subjects   
DII scores and the median intakes of selected nutrients including iron, MFP 
(meat, fish, poultry), protein, fiber and fat by BMI category are reported in (Table 
3).  There were no significant differences among BMI categories for the nutrients 
reported.  Among all participants, the DII scores ranged from a maximally anti-
inflammatory score of -4.2 to a maximally proinflammatory score of 3.7.  Cluster 
analysis of the scores grouped them into distinctly anti (-4.2 to 0.7) or pro inflammatory 












Table 3.  Selected Nutrient Intakes and DII Scores According to BMI 
 
Factor/Nutrient Normal Weight Overweight Obese P-value 



















































Inflammatory and Iron Status Biomarkers  
 
CRP concentration was highest among the subjects with obesity [3.63 (2.98, 4.43) 
mg/L], and lowest among subjects with normal weight [0.40 (0.32, 0.48) mg/L] (P< 0.05 
for all comparisons) (Table 4).  A trend toward poor iron status as BMI category 
increased was reflected in most iron status biomarkers (serum iron, Tsat and TIBC), 
however, only serum iron was significantly higher in normal weight (103+10µg/d) 
compared to obesity (72.6 +6µg/d) category (p=0.01).   Hepcidin concentrations were 
nearly twice as high in subjects with obesity compared to those with normal weight but 






Table 4.  Inflammatory and Iron Status Biomarkers According to BMI 
 


















Ferritin1  (ng/ml) 37(31, 45) 33 (28,39) 51 (43,61) 39 (35,49) 0.2 
Serum iron 
(µg/dL) 
103+10a 83+6a,b 72+6b 85+4 0.014 
Transferrin 
saturation (%) 
31.3+3.4 26.1+1.9 23.0+2.0 26.6+1.4 0.07 
Hemoglobin 
(g/dL) 
13.6+0.3 13.1+0.4 13.5+0.3 13.4+0.2 0.6 












1Data were log transformed.  Values are geometric means (geometric mean -1SE, 
geometric mean +1SE) 
 
 
Associations of DII with CRP and Hepcidin Concentrations    
 
Using linear regression, we investigated the association between the DII scoring 
as a continuous variable and inflammation as assessed using CRP concentration (Table 
5).  We found that CRP concentration increased with increasing DII score (β+SE = 





0.54+0.17, p=0.002).  In this model, having overweight (β+SE= 0.63+0.26, p=0.020) or 
obesity ((β+SE= 2.17+0.28, p < 0.001) was associated with higher CRP compared to 
subjects having normal weight. 
We also determined the association between DII as a categorical variable and 
CRP concentration (Table 6). In this model, the relationship between DII category and 
CRP was not statistically significant (β+SE = -0.45+0.25, p=0.076).  Also, although the 
anti-inflammatory diet category was associated with lower hepcidin concentration, this 
was not statistically significant (β+SE = -0.29+0.17; p = 0.095). 
 
Table 5.  Associations of DII Scores with CRP and Hepcidin  
 
 CRP, mg/L (n=98) Hepcidin, ng/mL (n=98) 
Predictors β SE p β SE p 
DII ® 0.23 0.07 0.002 0.03 0.06 0.546 
Energy, cal 0.54 0.17 0.002 0.06 0.1 0.63 
BMI Category       
 Obese 2.17 0.28 <0.001 0.30 0.27 0.269 
 Overweight 0.63 0.26 0.02 0.21 0.20 0.286 
CRP1 (mg/L)   0.07 0.08 0.378 
Ferritin1 (ng/mL)   0.85 0.09** <0.001 
Regression models were adjusted for age, sex and ethnicity. 
DII = Dietary Inflammatory Index 






Table 6.  Associations of DII Category with CRP and Hepcidin 
 
 CRP (mg/L) Hepcidin (ng/mL) 
Predictors β SE p β SE p 
DII category       
Anti-
inflammatory 
-0.45 0.25 0.076 -0.29 0.17 0.095 
Energy, cals 0.4 0.1 0.018 0.1 0.1 0.383 
BMI 
category 
      
Obese 2.25 0.29 <0.001 0.33 0.26 0.214 
Overweight 0.72 0.27 0.010 0.24 0.19 0.225 
CRP1 (mg/L)    0.06 0.07 0.411 
Ferritin1 
(ng/dL) 
   0.85 0.09 <0.001 
Regression models were adjusted for age, sex and ethnicity 
DII = Dietary Inflammatory Index 
1Data were log transformed.  Values are geometric means (geometric mean -1SE, 
geometric mean + 1SE) 
 
 
Associations of Inflammatory Diets with Iron Status Biomarkers   
 
DII score was an independent predictor of TIBC when analyzed as a continuous 
variable ((β+SE= -8.46+3.44, p=0.016) (Table 7).  DII scores were not however related 
to serum iron.  Only the obese category was predictive of lower serum iron while ferritin 





were associated with high TIBC (β+SE= 29.87+10.75, p=0.007) (Table 8). This 
relationship was independent of other iron status biomarkers. 
 
Table 7.  Associations of DII Scores with Iron Status Biomarkers 
  Serum iron, µg/dL (n=97) TIBC, µg/dL (n=98) 
Predictors β SE p β SE p 
DII ® 1.98 2.63 0.454 -8.46 3.44 0.016 
Energy, Cal 0.00 0.01 0.720 0.00 0.01 0.809 
BMI Category       
 Obese -27.11 12.31 0.030 -4.16 16.36 0.80 
 Overweight -14.24 9.18 0.125 -12.43 12.05 0.305 
CRP1 mg/L -4.99 3.61 0.171 5.14 4.79 0.287 
Ferritin1 ng/mL 14.55 4.30 0.001 -43.33 5.71 <0.001 
 Regression models were adjusted for age, sex, ethnicity and MFP. 
1CRP = C-Reactive Protein 


















Table 8.  Associations of DII Category with Iron Status Biomarkers 
 
 Serum iron, µg/dL (n=97) TIBC, µg/dL (n=98) 
 β SE p β SE p 
DII Category  
Anti-inflammatory 2.03 8.20 0.805 29.87 10.75 0.007 
Energy, Cal -0.00 0.01 0.867 0.00 0.01 0.552 
BMI Category       
 Obese -29.03 12.28 0.020 -3.03 16.10 0.851 
 Overweight -14.15 9.23 0.129 -15.23 11.98 0.207 
CRP1 mg/L -3.93 3.48 0.262 3.57 4.55 0.435 
Ferritin1 ng/mL 15.33 4.24 <0.001 -44.58 5.57 <0.001 
Regression models were adjusted for age, sex, ethnicity, and MFP intake. 
1CRP = C-Reactive Protein 
DII= Dietary Inflammatory index 





Systemic inflammation can be triggered by several factors including diet and 
obesity (44,177,184,185) and can lead to adverse health outcomes such as type 2 diabetes 
and cardiovascular diseases. Recent studies have shown that inflammation may also play 
a role in iron status regulation through the protein hepcidin. For example, low grade 
inflammation in obesity has been implicated in the poor iron status observed among 





through their heme and nonheme iron contents, it is not clear if their inflammatory and 
anti-inflammatory properties also influence iron status. In this study, we investigated the 
relationship between the inflammatory score of diets assessed using the DII and 
circulating iron biomarkers, namely serum iron and TIBC, adjusting for obesity status 
and other potential confounders. We chose the circulating iron biomarkers because 
elevated hepcidin concentration directly reduces circulating iron through poor iron 
absorption or iron sequestration (91,176,188). 
Median nutrient intakes in our studies were not significantly different among the 
three BMI categories (normal weight, overweight and obese). Compared to other studies 
(189), we found a much higher median MFP intake in our study population  (5.08 ounces 
or 142 g vs 91 g) despite similarities in age group. This is due to the fact that the dietary 
intakes of subjects in their study were modified in some cases. On the other hand, fiber 
intake data by BMI in our study is similar to those among US college students reported 
by Garcia-Meseguer (190) in a study of fiber patterns among college students in three 
different countries (Spain, USA and Tunisia).  They observed median fiber intakes 
among USA students of 18.1g, 15.3g and 18.3g in normal weight, overweight, and obese 
participants respectively compared to 17.28, 14.41 and 16.68 among our study 
participants.   
DII scores in our study ranged from -4.44 to 3.49 with median of 0.99. The lowest 
DII score in this study compares favorably to the -4.93 minimum DII score reported in 





(191), although they reported DII scores much higher than our maximum value of 
3.49.  Median DII scores in our study did not differ significantly among the different 
BMI categories (p=0.8).  In a study of associations between body weight and dietary 
inflammation, Muhammad et al. (192) also found no associations between BMI and DII 
as a continuous variable or with DII tertile. While these support our findings, the contrary 
was reported by Ruiz-Canela et al. (193) who found a positive association between the 
two variables in a population with high risk for CVD.  In this study, the correlation was 
found only among women and all the study participants were at least 55y.  In a college 
setting similar to our study, Kim et al.(194) compared DII scoring with HEI and glycemic 
index scores.  In their study, DII was positively correlated with glycemic index (GI) and 
inversely correlated with HEI. Wirth et al., also reported negative correlations between 
the DII scores of young adults and the HEI-2010 (r = −0.65, P < .01), AHEI (r = −0.55,P 
< .01), as well as the DASH diet (r = −0.52,P < .01).  Even though DII scores were also 
not associated with BMI, lower DII values were found in individuals with the lowest 
waist-to-hip ratios (WHR), a reliable indicator of central adiposity (195–198).  However 
we did not have WHR measures for our analyses. 
In our study, geometric mean of CRP was 1.1 mg/L (0.9, 1.2).   In two recent 
studies of young adults, mean CRP was found to be 1.72 mg/L and 1.5 mg/L 
(199,200).  Our lower value may be due to the fact that we reported the geometric mean, 
while these studies reported the arithmetic mean. Our findings showed that CRP 





lowest in the normal weight category. This affirms what has been reported in several 
earlier studies (201,202).  
We also found in a positive association between DII score and CRP 
concentration, which attests to the ability of the DII score to predict inflammation. Our 
results also corroborate the findings from several other studies (164,167,200,201).  For 
example, Boden et al. (203) observed that DII predicted 1.7% of elevated CRP in a 
prospective case control study of 1,389 verified cases of first myocardial infarction (MI). 
Wirth et al.  (167) reported positive associations between DII scores and CRP levels 
among African Americans in the fourth quartile of DII category in baseline data of the 
Healthy Eating and Active Living in the Spirit (HEALS) intervention study. In our 
regression analyses that included DII scores, both DII scores and overweight and obesity 
status categories were predictors of CRP suggesting that diet in addition to increased 
adiposity may contribute to the higher CRP among young adults. Dietary factors are 
shown to trigger inflammation via NFk-β activation and subsequent induction of 
inflammatory cytokines through upregulated innate immune signaling of toll like 
receptors-4 (TLR-4) and via the NRLP3 complex (124,154,204). High fat diets, 
particularly those high in saturated and trans fatty acids are shown to increase 
inflammation in mouse models and human studies while diets low in animal products are 
known to be anti-inflammatory.  In an early mouse model, Lumeng et al. (205) found that 
a high-fat diet increases the inflammatory properties of macrophages recruited by adipose 





increased systemic inflammation and acceleration of adiposity via increased TLR4 
signaling by high fat diet induced endotoxemia in the intestinal lumen of mice. In 
humans, a recent meta-analysis that controlled for weight loss reported that plant-based 
diets were independently associated with reductions in CRP in subjects with obesity 
(207). 
We also compared iron status and inflammatory markers among the different BMI 
categories. While other iron status biomarkers did not differ significantly, serum iron was 
significantly lower among subjects with obesity compared to those with normal weight 
(p=0.014). It is well documented that obesity is a risk factor for poor iron status 
(19,170,172,208) and the impaired iron status in obesity has been attributed to factors 
such as inflammation and concomitant elevated hepcidin concentration. Citelli et al. 
(179) reported increased hepcidin gene expression and iron accumulation in spleen and 
liver tissues as well as reductions in ferroportin (FPN) gene expression in obese mice fed 
a high fat diet.  In humans, a combined cross-sectional and longitudinal case control 
study by Moreno-Navarette et al.,(188) reported increased serum hepcidin, ferritin and 
hepatic iron content (HIC) among patients with obesity along with subsequent 
improvement in these values after dietary weight loss interventions. Chang et al. (2014 
REF) observed associations of fat to carbohydrate ratios with BMI among women with 
iron deficiency anemia (IDA) but not among healthy women.  Their findings showed a 
positive relationship between BMI and fat consumption (p = 0.035) and an inverse 





studies suggest that obesity alone is not responsible for the alterations of iron metabolism 
in obesity (15,209,210).  Therefore, in the present study we investigated how dietary 
inflammation, assessed through the DII scoring methodology, influences iron status 
independent of obesity related inflammation. 
During inflammation, the iron transport protein transferrin is a negative acute 
phase protein, and its production, therefore is downregulated, reducing its concentration 
(211–214).  In a female rat model, Zeid et al. (215) observed reduced TIBC in obese 
Wistar rats fed a high fat diet compared to control non obese mice fed standard chow.  
The researches also reported lower serum iron and transferrin saturation in high fat diet.  
This same study reported increased hepcidin, IL-6, ferritin and plasma leptin in the obese 
rats compared to control.  In the regression analyses of our study, higher DII scores 
predicted lower TIBC levels which suggests lower transferrin levels among subjects 
whose diets were estimated to have had higher inflammatory effects.  TIBC is reduced in 
both iron replete and inflammatory states.  Since our analyses controlled for meat, 
poultry, fish intake and as well as for other iron status biomarkers, it is more likely that 
the inflammatory effects of the diet predicted reduced TIBC rather than increased iron 
intake. 
Limitations 
While data from the present study were from mostly female subjects (72%) which 
could affect the value of the iron status biomarkers, we did not find a significant 





of this study’s results is that the current version of the DII which is weighted toward anti-
inflammatory components does not score more recently studied food components such as 
added sugars, non-nutritive sweeteners and advanced glycation end products which were 
common among the dietary records of the study’s sample.   Future studies are needed to 
determine the effects of dietary inflammation on transferrin production by the liver, as 
well as longitudinal investigations into how added sugars, non-nutritive sweeteners and 
the cooking effects of manufactured edible oils may influence inflammatory and 
micronutrient status. 
Conclusion 
In conclusion, we are the first to use the DII to examine the inflammatory effects 
of diet on circulating iron biomarkers and to demonstrate a relationship between 
inflammatory diets and decreased TIBC.  While it may be easy to presume that the effects 
of weight gain, including increased adiposity, alone account for poor health outcomes, 
lifestyle factors such as diet and activity patterns may play a key differentiating role.  In 
this study we have demonstrated that diet, independent of body weight status, predicts 
inflammation among young adults.  This implies that less inflammatory diets can be 
prescribed for reducing inflammation in all patients independent of weight status and for 
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